GILD Competitors
Gilead Sciences, Inc.
$147.10
+$0.25(+0.17%)
60
Overall
80
Value
41
Tech
60
Quality
Market Cap
$182.09B
Volume
4.49M
52W Range
$112.41 - $157.29
Target Price
$159.41
GILD competitors: AMGN, VRTX, ABBV, BIIB, ILMN. Gilead Sciences, Inc. is compared with its Healthcare peers on market cap, P/E ratio, dividend yield and performance.
GILD Competitors Compared
| Company | Price | Market cap | EPS est. (current yr) | Dividend yield | MarketXLS Rank |
|---|---|---|---|---|---|
| AMGN Amgen Inc. | $406.88 | $223.32B | $22.94 | 2.44% | 59 |
| VRTX Vertex Pharmaceuticals Incorporated | $507.29 | $128.16B | $16.68 | - | 51 |
| ABBV AbbVie Inc. | $272.36 | $479.52B | $14.05 | 2.51% | 62 |
| BIIB Biogen Inc. | $217.97 | $32.82B | $12.41 | - | 64 |
| ILMN Illumina, Inc. | $264.57 | $40.43B | $5.36 | - | 64 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | GILD | $147.10 | +0.2% | 4.49M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |